FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16139311000001106: Augmentin 625mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57042101000001115 Augmentin 625mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57042201000001110 Augmentin 625mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Augmentin 625mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Is a Co-amoxiclav 500mg/125mg tablets true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Is a Co-amoxiclav 500mg/125mg tablets false Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Is a Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Is a Augmentin true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Augmentin 625mg tablets (Lexon (UK) Ltd) 12 tablet Has AMP True Augmentin 625mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier
Augmentin 625mg tablets (Lexon (UK) Ltd) 21 tablet Has AMP True Augmentin 625mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start